Hussein Sabit

1.6k citations
79 papers · 1.0k · 1 hit paper · h-index 21

Impact in

Papers in

    • Epigenetics and DNA Methylation 8
    • Gut microbiota and health 7
    • Circular RNAs in diseases 6
    • MicroRNA in disease regulation 10
    • Cancer Genomics and Diagnostics 5

Hussein Sabit

74 papers receiving 989 citations

Hussein Sabit's Hit Papers

Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery 2025 · 69 citations
690Years since publication204060

Peers

Hussein Sabit
Comparison fields: 5 of 117
  • Infectious Diseases 131
  • Biomaterials 89
  • Biological Psychiatry 15
  • Cancer Research 90
  • Molecular Biology 351
Replace Reza Heidari with:
Reza Heidari Iran
Weibo Zhao China
Rashmi Kumari India
Masoumeh Zahmatkeshan Iran
Chenyang Wang China
Ying Liao China
Asaad Azarnezhad Iran
Soojin Park South Korea
JoEllyn McMillan United States
Shiow‐Yi Chen Taiwan
Hussein Sabit relative to Reza Heidari Iran Reza Heidari's profile →
Citations per field
00.5×2.6×
Reza Heidari · 1×
Citations per year

Countries citing papers authored by Hussein Sabit

Since Specialization
Citations

This map shows the geographic impact of Hussein Sabit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hussein Sabit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hussein Sabit more than expected).

Fields of papers citing papers by Hussein Sabit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hussein Sabit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hussein Sabit. The network helps show where Hussein Sabit may publish in the future.

Co-authors

The 25 scholars most cited alongside Hussein Sabit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hussein Sabit Line = papers co-authored together Hussein Sabit links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
Hit paper breakdown →
202569
2 202265
3 202051
4 202051
5 202246
6 202143
7 202138
8 202038
9 202035
10 201929
11 202126
12 202026
13 202325
14 202525
15 202425
16 202025
17 202024
18 201924
19 202023
20 202522

About Hussein Sabit

Hussein Sabit is a scholar working on Molecular Biology, Cancer Research, Infectious Diseases, Oncology and Biomedical Engineering, having authored 79 papers that have together received 1.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Epigenetics and DNA Methylation (8 papers), Gut microbiota and health (7 papers), Circular RNAs in diseases (6 papers), COVID-19 Clinical Research Studies (5 papers), Cancer Genomics and Diagnostics (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Infectious Diseases (131 citations), Biomaterials (89 citations), Biological Psychiatry (15 citations), Cancer Research (90 citations) and Molecular Biology (351 citations). Hussein Sabit has collaborated with scholars based in Egypt, Saudi Arabia and Germany. Frequent co-authors include Shaimaa Abdel-Ghany, Hüseyin Tombuloğlu, Emre Çevik, Mohamed Abdel-Hakeem, Ebtesam A. Al-Suhaimi, Güzin Tombuloğlu, Suriya Rehman, Borros Arneth, Ahmed El-Hashash and Reem Al Jindan. Their work appears in journals such as Pharmaceuticals, Biomedicines, Scientific Reports, Cancers and Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact